Acid reflux pills cause 8 times the cancer risk

Acid reflux pills cause 8 times the cancer risk
Proton pump inhibitors such as omeprazole are known to damage the gut microbiome, but the latest research shows that the greatly increase your risk of stomach cancer (gastric cancer) by up to 8 times depending how long you take them.
PPIs linked to massive stomach cancer increased risk
‘PPI’ (proton pump inhibitor) pills, dished out by Doctors and pharmacies throughout the Western world to millions of people for their ‘indigestion’ or 'to restrict your stomach acid and to prevent ulcers forming', have now been linked to significant increases in stomach cancer or gastric cancer, according to research by the University College London and University of Hong Kong scientists (1).
The most commonly used PPI is Omeprazole; others include Lansoprazole, Rabeprazole, Patoprazole and Esomeprazole.
Proton Pump Inhibitors have a destructive role on the gut microbiome and have even been linked with an increased risk of Clostridium difficile, which is more commonly assiated with repeated doses of antibiotics!
High doses and long-term use were previousl;y associated with lowered B-12 levels, lowered magnesium levels and a higher risk of osteoporosis. People taking PPIs for a long time have an increased risk of heart attacks.  Other side-effects according to Web MD include reduced liver and/or kidney function, allergies, pancreatitis and Erythema multiforme (Skin blotches and erruptions)
This recent study showed that people who use proton pump inhibitors for their ‘acid reflux problems’ are twice as likely as non-users to develop stomach cancer. But if they use the drugs regularly, that risk rises to 5-fold after one year and an incredible 8-fold after three years.  
The research results were published in the British Medical Journal ‘Gut’. The researchers noted that the increase in stomach cancer (or gastric cancer) was dose-dependent. If you take just one tablet a week your risk doubles over non-users, But for daily users, after one year the rise in risk was 4.5 and at three years it was 8.3.
The researchers treated the 63,000 subjects with antibiotics to kill Helicobacter pylori at the start of the study. This was because the bacterium itself can cause stomach cancer and they wanted to rule out any involvement. PPIs are often used with drugs to kill H. pylori anyway.

Increased stomach cancer, throat and esophageal cancers?
Chris Woollams, former Oxford University Biochemist and founder of CANCERactive stated, “PPIs can often be obtained without prescription yet we have told regular readers of this column before how they are one of the worst drugs for the destruction of commensal bacteria in the gut. We have told readers that Helicobacter pylori causes both damage and acid reflux leading to stomach and oesophageal cancers; and even some throat cancers. 
Furthermore, this research was done because it was known H. pylori and PPIs together caused GREATER stomach atrophy, so we are not surprised by these research results at all. I myself was offered on-going omeprazole by a quite insistent Doctor even though I don't have acid reflux and I told her about this research. I'd only gone for a blood sugar and cholesterol check!
The current finding reminds me of the HRT studies of more than a twenty years ago. We warned people then that there was clear research that HRT caused a three-fold increase in cancer. But all the Health Authorities played it down. Just a few months ago Cancer Research UK finally issued a similar warning. Rather than wait and watch the death toll mount as we did with HRT, why not ban proton pump inhibitors now? Alternative ‘indigestion’ treatments do exist. H2 blockers were not linked with increased risks of cancer.”
1. Ka Shing Cheung, Esther W Chan, Angel Y S Wong, Lijia Chen, Ian C K Wong, Wai Keung Leung;
2017 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Chris'

Join Chris' NewsletterSignup today for free and be the first to get notified on new updates.